Abstract
N-substituted 1,4-dihydropyridines bearing a carboxyl group at the 4-position were synthesized in solvent-free conditions with Cu2+ as the catalyst, imine and β-ketoester as starting materials. The possible mechanism which consists of addition-rearrangement process was proposed and examined by the reaction of isolated product of first addition to β- ketoester.
Keywords: Dihydropyridines, addition-rearrangement, Cu2+-catalyzed, imines, β-ketoester, solvent-free
Letters in Organic Chemistry
Title: Synthesis of New 1, 4-Dihydropyridines by Addition-Rearrangement Process with Imine Derivatives and β-Ketoester as Starting Materials in Solvent-Free Conditions (SUPPORTING INFORMATION)
Volume: 6 Issue: 3
Author(s): Xueming Chen, Xiaoguang Huang, Yunyun Chen, Feng He and Xingshu Li
Affiliation:
Keywords: Dihydropyridines, addition-rearrangement, Cu2+-catalyzed, imines, β-ketoester, solvent-free
Abstract: N-substituted 1,4-dihydropyridines bearing a carboxyl group at the 4-position were synthesized in solvent-free conditions with Cu2+ as the catalyst, imine and β-ketoester as starting materials. The possible mechanism which consists of addition-rearrangement process was proposed and examined by the reaction of isolated product of first addition to β- ketoester.
Export Options
About this article
Cite this article as:
Chen Xueming, Huang Xiaoguang, Chen Yunyun, He Feng and Li Xingshu, Synthesis of New 1, 4-Dihydropyridines by Addition-Rearrangement Process with Imine Derivatives and β-Ketoester as Starting Materials in Solvent-Free Conditions (SUPPORTING INFORMATION), Letters in Organic Chemistry 2009; 6(3) . https://dx.doi.org/10.2174/157017809787893082
DOI https://dx.doi.org/10.2174/157017809787893082 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
Related Journals
Related Books

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets A Pictorial Review of Intracranial Haemorrhage Revisited
Current Medical Imaging Alstrom Syndrome: Genetics and Clinical Overview
Current Genomics Nephron Number Reduction and Low Birth Weight: A Concern for the Paediatrician and Beyond
Current Pediatric Reviews Clinical Significance of the Sympathetic Nervous System in the Development and Progression of Pulmonary Arterial Hypertension
Current Neurovascular Research Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers Cardiovascular Effects of Omega-3 Free Fatty Acids.
Current Vascular Pharmacology Metabolic Syndrome and Psychiatric Practice: Clinical and Management Issues
Current Psychiatry Reviews Impact of Guidelines on Hypertension Control in the Elderly
Current Pharmaceutical Design Urinary Steroids Measured by Modern Separation Techniques and Applied as Biomarkers in Stress Studies
Current Pharmaceutical Analysis Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors
Current Pharmaceutical Design Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Neurovascular Changes in Acute, sub-Acute and Chronic Mouse Models of Parkinson’s Disease
Current Neurovascular Research Rational Basis for Nutraceuticals in the Treatment of Glaucoma
Current Neuropharmacology NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts
Inflammation & Allergy - Drug Targets (Discontinued) An 8-Year Retrospective Study of Human Visceral Leishmaniasis
Current Clinical Pharmacology Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?
Current Pharmaceutical Design Obesity-Induced Hypertension: New Insights
Current Pharmaceutical Design Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Current Alzheimer Research Editorial [Hot Topic: Recent Developments in Prodrug Design: Drug Targeting, Pharmacological and Pharmacokinetic Improvements Related to a Reduction of Adverse Effects (Guest Editors: Daniela Melisi & Maria Grazia Rimoli)]
Current Topics in Medicinal Chemistry